• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
    • Antitrust Litigation
  • Current Cases
  • KSF News
  • Client Login
  • Asset Recovery Services
  • Contact KSF

Court Appoints KSF as Lead Counsel in Orexigen Securities Fraud Class Action

Home»News»Court Appoints KSF as Lead Counsel in Orexigen Securities Fraud Class Action

On June 22, 2015, the United States District Court for the Southern District of California appointed KSF as sole lead counsel in In re Orexigen Therapeutics, Inc., Securities Litigation, 15cv540 L (KSC), stating,”[t]he Court has reviewed the firm’s resume, See Abadou Decl., Exh. D, ECF No. 37-6, and is satisfied that the lead plaintiff has made a reasonable choice of counsel. The Kahn Swick & Foti firm has extensive experience in the prosecution of securities class actions and it appears that it will adequately represent the interests of all class members.”

Filed Under: News

Previous Post: « Notice of Settlement of Star Scientific Derivative Litigation
Next Post: Court Denies Motion to Dismiss in CytRx Securities Class Action »

Primary Sidebar

Current Cases

Cabot Oil & Gas Corporation (NYSE: COG)

Amyris, Inc. (NasdaqGS: AMRS)

Obalon Therapeutics, Inc. (NasdaqGS: OBLN)

Coherent, Inc. (NasdaqGS: COHR)

Penumbra, Inc. (NYSE: PEN)

Anchiano Therapeutics Ltd. (NasdaqGS: ANCN)

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

© 2006-2021 Copyright. All rights reserved Kahn Swick & Foti LLC · New Orleans · New York — Kahn Swick & Foti LLP · San Francisco

We recently updated our Privacy Policy. We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.OkPrivacy policy